The glucocorticoid therapy influence on the lung microcirculation in patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 353s Year: 2005
The influence of different ways of steroid administration on the hemostasis parameters of bronchial asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 421s Year: 2003
Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Inhaled corticosteroids and β2 -agonists reduces imbalance in the cellular redox status in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
The lung microcirculation changes in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 407s Year: 2006
Effect of aerobic training on airway inflammation and symptoms in asthmatic patients maintaining corticosteroid treatment Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients Source: Annual Congress 2011 - Asthma management and response Year: 2011
The role of thyroid deficiency in alteration of functional activity of bronchial β-adrenoreception in patients with bronchial asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids Source: Eur Respir J 2002; 20: Suppl. 38, 480s Year: 2002
Changes in lung function and airway eosinophilia after reduction of ICS treatment and recurrence of asthmatic symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 547s Year: 2003
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002
Influence of endogenous corticosteroids on bronchial protective properties of β2 -agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
The changes of airway responsiveness in patients with bronchial asthma during the long term observation Source: Eur Respir J 2007; 30: Suppl. 51, 339s Year: 2007
The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003
The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018